Products

metapass

Tokenize your ticketing experience.

metapasshq.xyz DiscordBusiness Operations / Event Management & Ticketing

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$12/mo
Lower than 69% of peersNiche median $21.59/mo
Creators
Jha Sundaram
@exxyzee· 7 followers
Launched
4y ago
2022-02-22 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@exxyzee
  • Launched on Product HuntLaunch

    On-chain ticketing platform for web3 and NFTs

    Feb 22, 2022 · 4y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2021-12-26

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Indie
Zero Fees
Studio
$12/mo

Trial: None · 1 paid tier ($12) · Observed 2026-11-08 · Source page

Entry price $12/mo, Lower than 69% of peers; “Event Management & Ticketing” median is $21.59/mo.View pricing benchmark

Pages & changes

Tracked since 2022-02-22

Key pages

Weekly snapshots
Home
www.metapasshq.xyz/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does metapass cost?
Indie: Zero Fees; Studio: $12/mo. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does metapass get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is metapass and what platforms does it support?
metapass is catalogued under Event Management & Ticketing: Tokenize your ticketing experience. Supported platforms: Web.

Related products in this category

Business Operations / Event Management & Ticketing

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.